Subtle Medical's SubtleHD Gains Health Canada Approval for MRI Efficiency
Subtle Medical has received Health Canada approval for its SubtleHD software, which aims to enhance MRI efficiency and image quality across Canada. Announced in a press release, SubtleHD is designed to significantly reduce MRI scan times by up to 80% and improve image quality without requiring new hardware.
This approval comes at a crucial time for Canada's healthcare system, where MRI wait times are among the longest in the developed world. SubtleHD's vendor-neutral integration allows it to seamlessly fit into existing MRI infrastructures, offering Canadian hospitals and imaging centers the ability to increase scan volumes and reduce patient wait times.
SubtleHD is part of the Subtle-ELITE package, which also includes SubtleSYNTH and SubtleALIGN, although these are still pending approval. With SubtleHD now available, Canadian healthcare providers can immediately begin using the software to enhance imaging capacity and deliver faster diagnoses.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 22 BioStack Raises $9.5 Million for Medical AI Data Network Oct 22 Warp Sciences Raises $215 Million to Automate Drug Discovery Labs Oct 22 FDA Clears RIVANNA BoneEnhance Software for Accuro XV Oct 22 Tufts Medicine Uses Humata Health to Automate Prior Authorization Oct 22 HHS Plans Sole Source Claude Contract With AnthropicLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
FDA Clears RIVANNA BoneEnhance Software for Accuro XV
Tufts Medicine Uses Humata Health to Automate Prior Authorization
Medical Image Analysis Software Market Forecast to Reach $6.3 Billion by 2031
DeepSight Technology Adds Scott Huennekens to Board
EDDA Technology Named to TIME HealthTech List for Second Year
Daily AI Brief: the AI news that matters, in your inbox.